{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:08:24Z","timestamp":1791317304632,"version":"4.3.1"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jconrel.2024.03.031","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T19:58:19Z","timestamp":1711051099000},"page":"25-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Antimicrobial sensitisers: Gatekeepers to avoid the development of multidrug-resistant bacteria"],"prefix":"10.1016","volume":"369","author":[{"given":"Hanfei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Badawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Ares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Lopez-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Rosa","family":"Mart\u00ednez-Larra\u00f1aga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Anad\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Ar\u00e1nzazu","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.03.031_bb0005","doi-asserted-by":"crossref","first-page":"E1022","DOI":"10.1016\/S2214-109X(21)00163-7","article-title":"Resetting the agenda for antibiotic resistance through a health systems perspective","volume":"9","author":"Cars","year":"2021","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0010","author":"CDC"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0015","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Burden of AMR Collaborative Group, Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/1348-0421.12887","article-title":"Current situation of carbapenem-resistant Enterobacteriaceae and Acinetobacter in Japan and Southeast Asia","volume":"65","author":"Akeda","year":"2021","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0025","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1126\/science.abl5997","article-title":"The post-antibiotic era is here","volume":"373","author":"Kwon","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0030","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz6992","article-title":"Biology of antimicrobial resistance and approaches to combat it","volume":"12","author":"Schrader","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0035","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1039\/C8NP00031J","article-title":"Nonribosomal antibacterial peptides that target multidrug-resistant bacteria","volume":"36","author":"Liu","year":"2019","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/molecules24010043","article-title":"Molecules that inhibit bacterial resistance enzymes","volume":"24","author":"Liu","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0045","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.jiph.2021.10.020","article-title":"Antibiotic resistance in microbes: history, mechanisms, therapeutic strategies and future prospects","volume":"14","author":"Uddin","year":"2021","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0050","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.tim.2019.05.003","article-title":"Antimicrobial tolerance and metabolic adaptations in microbial biofilms","volume":"27","author":"Crabb\u00e9","year":"2019","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0055","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.3390\/ijms20235844","article-title":"Strategies to overcome antimicrobial resistance (AMR) making use of non-essential target inhibitors: a review","volume":"20","author":"Annunziato","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0060","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1021\/acs.jmedchem.9b02109","article-title":"Antibiotic adjuvants: make antibiotics great again! J. Med. Chem. 62 (2019) 8665-8681","volume":"63","author":"Douafer","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0065","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03084-21","article-title":"Genetic dissection of antibiotic adjuvant activity","volume":"13","author":"Bailey","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0070","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3390\/antibiotics12111590","article-title":"Evaluation of antibiotic resistance mechanisms in gram-negative bacteria","volume":"12","author":"Gauba","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0075","doi-asserted-by":"crossref","first-page":"8198","DOI":"10.1038\/s41467-023-43624-1","article-title":"Staphylococcus aureus functional amyloids catalyze degradation of \u03b2-lactam antibiotics","volume":"14","author":"Arad","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13567-022-01111-3","article-title":"How Streptococcus suis escapes antibiotic treatments","volume":"53","author":"Uru\u00e9n","year":"2022","journal-title":"Vet. Res."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0085","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/14787210.2020.1730178","article-title":"Mechanisms of antimicrobial resistance in Stenotrophomonas maltophilia: a review of current knowledge","volume":"18","author":"Gil-Gil","year":"2020","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0090","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1093\/jac\/dkaa189","article-title":"Phenotypic and genotypic quinolone resistance in Escherichia coli underlining GyrA83\/87 mutations as a target to detect ciprofloxacin resistance","volume":"75","author":"Muggeo","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0095","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/biomedicines11030878","article-title":"Prevalence of mecA- and mecC-associated methicillin-resistant Staphylococcus aureus in clinical specimens, Punjab, Pakistan","volume":"11","author":"Idrees","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0100","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.tim.2021.11.002","article-title":"Targeting bacterial outer-membrane remodelling to impact antimicrobial drug resistance","volume":"30","author":"Rosas","year":"2022","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0105","doi-asserted-by":"crossref","first-page":"15779","DOI":"10.3390\/ijms232415779","article-title":"Role of efflux pumps on antimicrobial resistance in Pseudomonas aeruginosa","volume":"23","author":"Lorusso","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0110","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1126\/science.1209855","article-title":"H2S: a universal defense against antibiotics in bacteria","volume":"334","author":"Shatalin","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0115","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1126\/science.abd8377","article-title":"Inhibitors of bacterial H2S biogenesis targeting antibiotic resistance and tolerance","volume":"372","author":"Shatalin","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0120","doi-asserted-by":"crossref","first-page":"16224","DOI":"10.1038\/nmicrobiol.2016.224","article-title":"An essential role for bacterial nitric oxide synthase in Staphylococcus aureus electron transfer and colonization","volume":"2","author":"Kinkel","year":"2017","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0125","doi-asserted-by":"crossref","first-page":"18127","DOI":"10.1073\/pnas.1314080110","article-title":"Structural and biological studies on bacterial nitric oxide synthase inhibitors","volume":"110","author":"Holden","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0130","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf4268","article-title":"Mechanisms of bacterial persistence during stress and antibiotic exposure","volume":"354","author":"Harms","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0135","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.molcel.2017.11.012","article-title":"Understanding and sensitizing density-dependent persistence to quinolone antibiotics","volume":"68","author":"Gutierrez","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0140","article-title":"Combating antibiotic tolerance through activating bacterial metabolism","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0145","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.aaj2191","article-title":"Antibiotic tolerance facilitates the evolution of resistance","volume":"355","author":"Levin-Reisman","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0150","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.chembiol.2016.12.015","article-title":"Carbon sources tune antibiotic susceptibility in Pseudomonas aeruginosa via tricarboxylic acid cycle control","volume":"24","author":"Meylan","year":"2017","journal-title":"Cell. Chem. Biol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000760","article-title":"SOS response induces persistence to fluoroquinolones in Escherichia coli","volume":"5","author":"D\u00f6rr","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0160","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cmet.2015.01.008","article-title":"Exogenous alanine and\/or glucose plus kanamycin kills antibiotic-resistant bacteria","volume":"21","author":"Peng","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0165","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.1038\/s41467-021-26456-9","article-title":"Hedgehog artificial macrophage with atomic-catalytic centers to combat drug-resistant bacteria","volume":"12","author":"Long","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0170","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.2147\/IJN.S382796","article-title":"Recent advances in nanozymes for bacteria-infected wound therapy","volume":"17","author":"Mo","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0175","article-title":"A library of ROS-catalytic metalloenzyme mimics with atomic metal centers","volume":"34","author":"Cao","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0180","doi-asserted-by":"crossref","first-page":"556","DOI":"10.7150\/ijbs.6.556","article-title":"Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro","volume":"6","author":"Jayaraman","year":"2010","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0185","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.biotechadv.2008.03.002","article-title":"Clavulanic acid: a review","volume":"26","author":"Saudagar","year":"2008","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0190","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nature13445","article-title":"Aspergillomarasmine A overcomes metallo-\u03b2-lactamase antibiotic resistance","volume":"510","author":"King","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0195","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/AAC.11.5.852","article-title":"Clavulanic acid: a beta-lactamase-inhibiting beta-lactam from Streptomyces clavuligerus","volume":"11","author":"Reading","year":"1977","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0200","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.cbi.2019.05.050","article-title":"Synergistic interactions of phytochemicals with antimicrobial agents: potential strategy to counteract drug resistance","volume":"308","author":"Ayaz","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0205","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/s41564-021-00952-6","article-title":"Biology and applications of co-produced, synergistic antimicrobials from environmental bacteria","volume":"6","author":"Meyer","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0210","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/antibiotics10010084","article-title":"Clavulanic acid production by Streptomyces clavuligerus: insights from systems biology, strain engineering, and downstream processing","volume":"10","author":"L\u00f3pez-Agudelo","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0215","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1128\/AAC.48.6.1968-1973.2004","article-title":"Epigallocatechin-gallate enhances the activity of tetracycline in staphylococci by inhibiting its efflux from bacterial cells","volume":"48","author":"Sudano Roccaro","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0220","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.phytochem.2005.06.008","article-title":"Multidrug resistance reversal agent from Jatropha elliptica","volume":"66","author":"Marquez","year":"2005","journal-title":"Phytochemistry"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.674560","article-title":"Unraveling the novel effect of patchouli alcohol against the antibiotic resistance of Helicobacter pylori","volume":"12","author":"Zhong","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0230","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0378-8741(00)00313-5","article-title":"4-Hydroxybenzaldehyde from Gastrodia elata B1. Is active in the antioxidation and GABAergic neuromodulation of the rat brain","volume":"73","author":"Ha","year":"2000","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0235","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1007\/s00253-018-8791-1","article-title":"4-Hydroxybenzaldehyde sensitizes Acinetobacter baumannii to amphenicols","volume":"102","author":"Shin","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0240","first-page":"2994","article-title":"Scientific opinion on flavouring group evaluation 20, revision 4 (FGE.20Rev4): benzyl alcohols, benzaldehydes, a related acetal, benzoic acids, and related esters from chemical groups 23 and 30","volume":"10","author":"EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF)","year":"2012","journal-title":"EFSA J."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.giant.2021.100066","article-title":"Combating antibiotic resistance: current strategies for the discovery of novel antibacterial materials based on macrocycle supramolecular chemistry","volume":"7","author":"Gao","year":"2021","journal-title":"Giant"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0250","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.coph.2019.03.004","article-title":"Recently developed synthetic compounds with anti-infective activity","volume":"48","author":"Gonz\u00e1lez-Bello","year":"2019","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0255","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/pro.3100","article-title":"Exploring the potential of boronic acids as inhibitors of OXA-24\/40 \u03b2-lactamase","volume":"26","author":"Werner","year":"2017","journal-title":"Protein Sci."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0260","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1358\/dot.2017.53.10.2721815","article-title":"Meropenem\/vaborbactam fixed combination for the treatment of patients with complicated urinary tract infections","volume":"53","author":"McCarthy","year":"2017","journal-title":"Drugs Today"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0265","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3390\/biom10060899","article-title":"Bicyclic boronates as potent inhibitors of AmpC, the class C \u03b2-lactamase from Escherichia coli","volume":"10","author":"Lang","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0270","doi-asserted-by":"crossref","first-page":"8544","DOI":"10.1021\/acs.jmedchem.9b00911","article-title":"Bicyclic boronate VNRX-5133 inhibits metallo- and serine- \u03b2 -lactamases","volume":"62","author":"Krajnc","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0275","doi-asserted-by":"crossref","first-page":"17028","DOI":"10.1038\/nmicrobiol.2017.28","article-title":"Pentamidine sensitizes gram-negative pathogens to antibiotics and overcomes acquired colistin resistance","volume":"2","author":"Stokes","year":"2017","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0280","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1021\/acsinfecdis.1c00482","article-title":"Preclinical development of pentamidine analogs identifies a potent and nontoxic antibiotic adjuvant","volume":"8","author":"MacNair","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0285","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1021\/acsinfecdis.2c00121","article-title":"Restoring and enhancing the potency of existing antibiotics against drug-resistant gram-negative bacteria through the development of potent small-molecule adjuvants","volume":"8","author":"Yu","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0290","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.3390\/ijms20194730","article-title":"Structure-based design and in silico screening of virtual combinatorial library of benzamides inhibiting 2-trans enoyl-acyl carrier protein reductase of Mycobacterium tuberculosis with favorable predicted pharmacokinetic profiles","volume":"20","author":"Kouman","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0295","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3389\/fcimb.2018.00173","article-title":"Cascade ligand- and structure-based virtual screening to identify new trypanocidal compounds inhibiting putrescine uptake","volume":"8","author":"Alberca","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0300","doi-asserted-by":"crossref","first-page":"15573","DOI":"10.1073\/pnas.1310459110","article-title":"Bio-inspired synthesis yields a tricyclic indoline that selectively resensitizes methicillin-resistant Staphylococcus aureus (MRSA) to \u03b2-lactam antibiotics","volume":"110","author":"Podoll","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0305","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/jam.15314","article-title":"Antimicrobial peptides (AMPs): a promising class of antimicrobial compounds","volume":"132","author":"Erdem B\u00fcy\u00fckkiraz","year":"2022","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0310","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.4155\/fmc-2019-0167","article-title":"Antimicrobial peptides with protease stability: progress and perspective","volume":"11","author":"Shao","year":"2019","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0315","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nrmicro2095","article-title":"Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations","volume":"7","author":"Melo","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0320","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41564-018-0164-0","article-title":"Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides","volume":"3","author":"L\u00e1z\u00e1r","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0325","doi-asserted-by":"crossref","first-page":"14937","DOI":"10.1021\/acs.jmedchem.0c01506","article-title":"Proline hinged amphipathic \u03b1-helical peptide sensitizes gram-negative bacteria to various gram-positive antibiotics","volume":"63","author":"Hyun","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.129113","article-title":"Overcoming intrinsic resistance in gram-negative bacteria using small molecule adjuvants","volume":"80","author":"Melander","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0335","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1128\/AAC.00405-08","article-title":"Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents","volume":"52","author":"Vaara","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0340","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01239-17","article-title":"SPR741, an antibiotic adjuvant, potentiates the in vitro and in vivo activity of rifampin against clinically relevant extensively drug-resistant Acinetobacter baumannii","volume":"61","author":"Zurawski","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0345","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1128\/AAC.01439-09","article-title":"A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane","volume":"54","author":"Vaara","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0350","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1021\/acsinfecdis.9b00159","article-title":"Potentiation of antibiotics against gram-negative bacteria by polymyxin B analogue SPR741 from unique perturbation of the outer membrane","volume":"6","author":"French","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0355","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00054-22","article-title":"Leaks in the pipeline: a failure analysis of gram-negative antibiotic development from 2010 to 2020","volume":"66","author":"Prasad","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0360","doi-asserted-by":"crossref","first-page":"9630","DOI":"10.1021\/acs.jmedchem.7b01064","article-title":"Novel linear lipopeptide paenipeptins with potential for eradicating biofilms and sensitizing gram-negative bacteria to rifampicin and clarithromycin","volume":"60","author":"Moon","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0365","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1021\/acsinfecdis.1c00147","article-title":"Antibiotic potentiation in multidrug-resistant gram-negative pathogenic bacteria by a synthetic peptidomimetic","volume":"7","author":"Mood","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0370","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.drup.2016.04.002","article-title":"Mechanisms and consequences of bacterial resistance to antimicrobial peptides","volume":"26","author":"Andersson","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0375","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1016\/S1473-3099(20)30327-3","article-title":"The value of antimicrobial peptides in the age of resistance","volume":"20","author":"Magana","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107990","article-title":"Antimicrobial peptides - unleashing their therapeutic potential using nanotechnology","volume":"232","author":"Gera","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170666","article-title":"Chemical modifications to increase the therapeutic potential of antimicrobial peptides","volume":"146","author":"Han","year":"2021","journal-title":"Peptides"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0390","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12917-020-02630-x","article-title":"Enhancing the antibacterial activity of antimicrobial peptide PMAP-37(F34-R) by cholesterol modification","volume":"16","author":"Chen","year":"2020","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106434","article-title":"The cathelicidin-derived close-to-nature peptide D-11 sensitises Klebsiella pneumoniae to a range of antibiotics in vitro, ex vivo and in vivo","volume":"58","author":"Cebri\u00e1n","year":"2021","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0400","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.resmic.2020.03.001","article-title":"Antimicrobial peptides against drug resistant Mycobacterium abscessus","volume":"171","author":"da Silva","year":"2020","journal-title":"Res. Microbiol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0405","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ijantimicag.2018.10.025","article-title":"Repurposing azithromycin and rifampicin against gram-negative pathogens by combination with peptide potentiators","volume":"53","author":"Baker","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0410","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.3390\/molecules25122917","article-title":"Synthesis of iron(II)-N-heterocyclic carbene complexes: paving the way for a new class of antibiotics","volume":"25","author":"Vinagreiro","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0415","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001363","article-title":"Evaluation of metal-based antimicrobial compounds for the treatment of bacterial pathogens","volume":"70","author":"Evans","year":"2021","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0420","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1007\/s00253-020-10600-4","article-title":"Iron and zinc ions, potent weapons against multidrug-resistant bacteria","volume":"104","author":"Ye","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0425","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00775-018-1544-x","article-title":"Synthesis and antibacterial activity of iron-hexacyanocobaltate nanoparticles","volume":"23","author":"Ciabocco","year":"2018","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0430","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/acs.accounts.1c00004","article-title":"Design and syntheses of new antibiotics inspired by nature\u2019s quest for iron in an oxidative climate","volume":"54","author":"Miller","year":"2021","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0435","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02280-17","article-title":"Copper ions and coordination complexes as novel carbapenem adjuvants","volume":"62","author":"Djoko","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0440","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00253-017-8671-0","article-title":"Advances in therapeutic bacterial antisense biotechnology","volume":"102","author":"Hegarty","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0445","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/418244a","article-title":"RNA interference","volume":"418","author":"Hannon","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0450","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.cell.2009.07.040","article-title":"RNA-guided RNA cleavage by a CRISPR RNA-cas protein complex","volume":"139","author":"Hale","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0455","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1093\/nar\/gku161","article-title":"CRISPR-mediated targeted mRNA degradation in the archaeon Sulfolobus solfataricus","volume":"42","author":"Zebec","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0460","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10529-013-1352-x","article-title":"Design of riboregulators for control of cyanobacterial (Synechocystis) protein expression","volume":"36","author":"Abe","year":"2014","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0465","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.molcel.2011.10.023","article-title":"Essential features and rational design of CRISPR RNAs that function with the Cas RAMP module complex to cleave RNAs","volume":"45","author":"Hale","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0470","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jconrel.2014.06.054","article-title":"RNAi for silencing drug resistance in microbes toward development of nanoantibiotics","volume":"189","author":"Edson","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0475","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/infdis\/jit460","article-title":"Gene-silencing antisense oligomers inhibit Acinetobacter growth in vitro and in vivo","volume":"208","author":"Geller","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0480","first-page":"782","article-title":"Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) restores carbapenem susceptibility to NDM-1-positive pathogens in vitro and in vivo","volume":"72","author":"Sully","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0485","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1021\/acsinfecdis.9b00123","article-title":"AcrAB\u2013TolC inhibition by peptide-conjugated phosphorodiamidate morpholino oligomers restores antibiotic activity in vitro and in vivo","volume":"5","author":"Sturge","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0490","doi-asserted-by":"crossref","first-page":"e01315","DOI":"10.1128\/mBio.01315-17","article-title":"MCR-1 inhibition with peptide-conjugated phosphorodiamidate morpholino oligomers restores sensitivity to polymyxin in Escherichia coli","volume":"8","author":"Daly","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0495","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1128\/AAC.00850-12","article-title":"Bacterial resistance to antisense peptide phosphorodiamidate morpholino oligomers","volume":"56","author":"Puckett","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0500","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jhepr.2019.09.002","article-title":"Using CRISPR\/Cas9 to model human liver disease","volume":"1","author":"Alves-Bezerra","year":"2019","journal-title":"JHEP Rep."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0505","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.gendis.2016.07.003","article-title":"CRISPR-mediated genome editing and human diseases","volume":"3","author":"Cai","year":"2016","journal-title":"Genes Dis."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2016.11.001","article-title":"Sensitizing pathogens to antibiotics using the CRISPR-cas system","volume":"30","author":"Goren","year":"2017","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0515","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.2147\/IDR.S370869","article-title":"The application of the CRISPR-Cas system in antibiotic resistance","volume":"15","author":"Tao","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0520","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3390\/antibiotics12061075","article-title":"CRISPR-Cas9 system: a prospective pathway toward combatting antibiotic resistance","volume":"12","author":"Javed","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0525","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrmicro3279","article-title":"Unravelling the structural and mechanistic basis of CRISPR-cas systems","volume":"12","author":"van der Oost","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0530","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.apsb.2021.05.020","article-title":"In vivo delivery of CRISPR-cas9 therapeutics: progress and challenges","volume":"11","author":"Behr","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0535","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/nbt.3043","article-title":"Exploiting CRISPR-cas nucleases to produce sequence-specific antimicrobials","volume":"32","author":"Bikard","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0540","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/nbt.3011","article-title":"Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases","volume":"32","author":"Citorik","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0545","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1073\/pnas.1500107112","article-title":"Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria","volume":"112","author":"Yosef","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0550","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4014\/jmb.1508.08080","article-title":"CRISPR\/cas9-mediated re-sensitization of antibiotic-resistant Escherichia coli harboring extended-spectrum \u03b2-lactamases","volume":"26","author":"Kim","year":"2016","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0555","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ymthe.2020.09.028","article-title":"CRISPR-cas9: a preclinical and clinical perspective for the treatment of human diseases","volume":"29","author":"Sharma","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0560","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2016.58","article-title":"CRISPR-cas9 for in vivo gene therapy: promise and hurdles","volume":"5","author":"Dai","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0565","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3390\/microorganisms9050954","article-title":"Cracking the challenge of antimicrobial drug resistance with CRISPR\/cas9, nanotechnology and other strategies in ESKAPE pathogens","volume":"9","author":"Zohra","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0570","doi-asserted-by":"crossref","first-page":"aad3292","DOI":"10.1126\/science.aad3292","article-title":"Multidrug evolutionary strategies to reverse antibiotic resistance","volume":"351","author":"Baym","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0575","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.drudis.2021.02.014","article-title":"Challenges and opportunities in the discovery, development, and commercialization of pathogen-targeted antibiotics","volume":"26","author":"Altarac","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0580","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1469-0691.2006.01528.x","article-title":"Impact of antibiotic restrictions: the pharmaceutical perspective","volume":"12","author":"Power","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0585","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.tips.2010.08.002","article-title":"The global need for effective antibiotics: challenges and recent advances","volume":"31","author":"H\u00f6gberg","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0590","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.mimet.2018.04.008","article-title":"Streptomyces thermoviolaceus SRC3 strain as a novel source of the antibiotic adjuvant streptazolin: a statistical approach toward the optimized production","volume":"148","author":"Djinni","year":"2018","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.jconrel.2024.03.031_bb0595","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00143-21","article-title":"Lytic bacteriophages facilitate antibiotic sensitization of Enterococcus faecium","volume":"65","author":"Canfield","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0600","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.tim.2018.12.010","article-title":"Alternatives to conventional antibiotics in the era of antimicrobial resistance","volume":"27","author":"Ghosh","year":"2019","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0605","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.chembiol.2016.11.011","article-title":"A common platform for antibiotic dereplication and adjuvant discovery","volume":"24","author":"Cox","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0610","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/j.bmcl.2017.08.027","article-title":"Antibiotic adjuvants - a strategy to unlock bacterial resistance to antibiotics","volume":"27","author":"Gonz\u00e1lez-Bello","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0615","article-title":"Spiky artificial peroxidases with V\u2212O\u2212Fe pair sites for combating antibiotic-resistant pathogens","volume":"63","author":"Huang","year":"2024","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2024.03.031_bb0620","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1093\/cid\/ciu530","article-title":"Innovation of novel antibiotics: an economic perspective","volume":"59","author":"McKellar","year":"2014","journal-title":"Clin. Infect. Dis."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924001846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924001846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T01:56:19Z","timestamp":1728525379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924001846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":124,"alternative-id":["S0168365924001846"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.03.031","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial sensitisers: Gatekeepers to avoid the development of multidrug-resistant bacteria","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.03.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}